Despite the concerns relating to the safety of drug eluting stents, surgeons are willing to accept these risks and continue avoiding traditional open heart surgery procedures. With many second generation Percutaneous Coronary Intervention (PCI) products in the pipeline, the use of open heart surgery will start to decline once the new PCI products are released into the market.
GlobalData's “Cardiovascular Surgery Pipeline Technology and Market Forecasts To 2015” is an essential source of data and information about the future of products and technologies in the global cardiovascular market. The report reviews specific pipeline devices and technologies and also provides a holistic overview of existing cardiovascular surgery products, the current market structure and competitive landscape.
For more information on this report click here:
http://www.global-
This new report will provide you with.
• Analysis and review of the key pipeline devices that are likely to impact the cardiovascular surgery landscape globally
• Independent analysis of the product details, indication details and clinical trial status with projections on the market potential
• Review of existing competing cardiovascular surgery technologies and the competitive landscape
• Review and analysis of the trends, drivers and restraints shaping and defining the markets that cardiovascular surgery products are being targeted in
• In-depth analysis of the device-specific developments, strategic partnerships and other details expected to influence the launch and market penetration
For more information on this report click here
http://www.global-
Or visit GlobalData’s Report Store:
http://www.globaldata.com/
